Fig. 3From: Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesiaPatient claims analyzed for MDD-related inpatient admissions after ≥10% dose reductions of antipsychotic medication. Outcomes for case and control cohorts were assessed using Kaplan–Meier analysis and compared using a log-rank test. The number of patients at risk is represented for each time point. Case and control cohorts for ≥10%, N = 17,766 each. CI: confidence interval; MDD: major depressive disorderBack to article page